CNS drug market to hit $235.9b by 2033 as neurological diseases surge
With global market valuation approaching the $2.5 trillion mark, mergers and licensing deals are accelerating. The global central nervous system (CNS) therapeutics market is expected to expand steadily over the next decade,
